Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer

SIMPLE SUMMARY: Treating biliary tract cancer (BTC) successfully remains to be a difficult task. Standard therapeutic options encompass surgery, radiation and chemotherapy, but the median survival has not improved beyond one year. The reasons for this might be diagnosis at an already late stage and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekric, Dino, Neureiter, Daniel, Ablinger, Celina, Dobias, Heidemarie, Beyreis, Marlena, Ritter, Markus, Jakab, Martin, Bischof, Johannes, Koller, Ulrich, Kiesslich, Tobias, Mayr, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000745/
https://www.ncbi.nlm.nih.gov/pubmed/36900361
http://dx.doi.org/10.3390/cancers15051569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000745/
https://www.ncbi.nlm.nih.gov/pubmed/36900361
http://dx.doi.org/10.3390/cancers15051569

Ejemplares similares